Big Gain For Alterity Therapeutics Limited
Alterity Therapeutics Limited (ATHE:NASDAQ) jumped higher at $1.19, a gain of 103.4%. On Mon 29 Jun 20, ATHE:NASDAQ touched a New 2-Week Intraday Low of $0.57. The stock got featured on our News Catalysts scanner on Tue 30 Jun 20 at 03:24 AM in the 'BIOTECH' category. From Mon 15 Jun 20, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu 21 May 20 at $1.3 with a volume of 15M+, and its share price has been moving sideways in recent weeks.
About Alterity Therapeutics Limited (ATHE:NASDAQ)
Prana Biotechnology Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.
Top 10 Gainers:
- Polar Power, Inc. (POLA:NASDAQ), 262.04%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 103.42%
- Apex Global Brands Inc. (APEX:NASDAQ), 80.65%
- Shiloh Industries, Inc. (SHLO:NASDAQ), 64.47%
- LGHL (LGHL:NASDAQ), 52.5%
- Qumu Corporation (QUMU:NASDAQ), 49.58%
- Blink Charging Co. (BLNK:NASDAQ), 41.65%
- CPS Technologies Corporation (CPSH:NASDAQ), 40.7%
- Oxbridge Re Holdings Limited (OXBR:NASDAQ), 40%
- Bloom Energy Corporation (BE:NYSE), 32.36%